LifePro Asset Management Sells 266 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

LifePro Asset Management decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,524 shares of the exchange traded fund’s stock after selling 266 shares during the period. LifePro Asset Management’s holdings in SPDR S&P Biotech ETF were worth $447,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Affinity Asset Advisors LLC raised its position in SPDR S&P Biotech ETF by 105.4% in the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after purchasing an additional 737,550 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of SPDR S&P Biotech ETF by 30.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after acquiring an additional 730,000 shares during the last quarter. Mirae Asset Securities USA Inc. purchased a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at about $55,626,000. Jane Street Group LLC grew its position in SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after acquiring an additional 391,333 shares during the last quarter. Finally, Baymount Management LP purchased a new position in SPDR S&P Biotech ETF in the 1st quarter worth approximately $34,160,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $96.22 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The firm has a market cap of $7.33 billion, a PE ratio of 11.47 and a beta of 1.11. The business has a 50 day moving average price of $98.50 and a 200-day moving average price of $94.12.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.